Literature DB >> 15757185

Sclerosing epithelioid fibrosarcoma: a case report.

Andrew P Battiata1, John Casler.   

Abstract

Sclerosing epithelioid fibrosarcoma (SEF) is a rare variant of fibrosarcoma. It is a mesenchymal neoplasm composed of round to oval cells dispersed in a nestlike or cordlike distribution on a highly collagenous tissue background and is now recognized as a distinct clinical entity. In this report we discuss the presentation, diagnosis, and treatment of SEF. We focus on the unique histologic and immunohistochemical properties of this lesion. It is essential for both the surgeon and the pathologist to be aware of SEF and include it in the differential diagnosis for atypical head and neck neoplasms. Sclerosing epithelioid fibrosarcoma is a rare neoplasm that is now listed among the low-grade neoplasms that may occur in the head and neck. However, its behavior tends to be typical of more aggressive lesions. An awareness of this characteristic of SEF is essential for clinicians and pathologists alike.

Entities:  

Mesh:

Year:  2005        PMID: 15757185     DOI: 10.1177/000348940511400201

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  8 in total

1.  Sclerosing epithelioid fibrosarcoma of the oral cavity.

Authors:  Camille T Elkins; Paul E Wakely
Journal:  Head Neck Pathol       Date:  2011-06-21

2.  Oral and maxillofacial sclerosing epithelioid fibrosarcoma: report of five cases.

Authors:  Gretchen S Folk; Stephen B Williams; Robert B Foss; Julie C Fanburg-Smith
Journal:  Head Neck Pathol       Date:  2007-10-26

Review 3.  Sclerosing epithelioid fibrosarcoma: case presentation and a systematic review.

Authors:  Christian Ossendorf; Gabriela M Studer; Beata Bode; Bruno Fuchs
Journal:  Clin Orthop Relat Res       Date:  2008-03-14       Impact factor: 4.176

4.  Sclerosing epithelioid fibrosarcoma of the bone: a case report of high resistance to chemotherapy and a survey of the literature.

Authors:  Thomas G P Grunewald; Irene von Luettichau; Gregor Weirich; Angela Wawer; Uta Behrends; Peter M Prodinger; Gernot Jundt; Stefan S Bielack; Reiner Gradinger; Stefan Burdach
Journal:  Sarcoma       Date:  2010-04-12

5.  Sclerosing epithelioid fibrosarcoma of the liver infiltrating the inferior vena cava.

Authors:  Yoshito Tomimaru; Hiroaki Nagano; Shigeru Marubashi; Shogo Kobayashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Toru Kitagawa; Koji Umeshita; Nobuyuki Hashimoto; Hideki Yoshikawa; Kenichi Wakasa; Yuichiro Doki; Masaki Mori
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

6.  Multiple bone metastasis of sclerosing epithelioid fibrosarcoma 12 years after initial surgery-increasing ki-67 labeling index.

Authors:  Atsuko Kanno; Masahito Hatori; Masami Hosaka; Koshi N Kishimoto; Munenori Watanuki; Mika Watanabe; Eiji Itoi
Journal:  Sarcoma       Date:  2009-03-29

7.  Sclerosing epithelioid fibrosarcoma: rare and serious.

Authors:  Mounir Yahyaoui; Mohammed Benhammou; Soufiane Aharram; Jawad Amghar; Mohammed Sadougui; Omar Agoumi; Abdelkrim Daoudi
Journal:  Pan Afr Med J       Date:  2020-06-25

Review 8.  Metastatic pediatric sclerosing epithelioid fibrosarcoma.

Authors:  Andrew D Woods; Charles Keller; Aman Wadhwa; Reshma Purohit; Laura Crocker Mitchell; John R Collier; Katherine A Collier; Melvin Lathara; Katrina Learned; Olena Vaske; Heather Geiger; Kazimierz O Wrzeszczynski; Vaidehi Jobanputra; Ganapati Srinivasa; Erin R Rudzinski; Kimberly Whelan; Elizabeth Beierle; Sheri L Spunt
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.